| Literature DB >> 29456792 |
Michael H Charlton1, Rihards Aleksis2, Adélaïde Saint-Leger3,4, Arya Gupta5, Einars Loza2, Lluís Ribas de Pouplana3,4, Ilze Kaula2, Daina Gustina2, Marina Madre2, Daina Lola2, Kristaps Jaudzems2, Grace Edmund1, Christopher P Randall5, Louise Kime5, Alex J O'Neill5, Wil Goessens6, Aigars Jirgensons2, Paul W Finn1,7.
Abstract
N-Leucinyl benzenesulfonamides have been discovered as a novel class of potent inhibitors of E. coli leucyl-tRNA synthetase. The binding of inhibitors to the enzyme was measured by using isothermal titration calorimetry. This provided information on enthalpy and entropy contributions to binding, which, together with docking studies, were used for structure-activity relationship analysis. Enzymatic assays revealed that N-leucinyl benzenesulfonamides display remarkable selectivity for E. coli leucyl-tRNA synthetase compared to S. aureus and human orthologues. The simplest analogue of the series, N-leucinyl benzenesulfonamide (R = H), showed the highest affinity against E. coli leucyl-tRNA synthetase and also exhibited antibacterial activity against Gram-negative pathogens (the best MIC = 8 μg/mL, E. coli ATCC 25922), which renders it as a promising template for antibacterial drug discovery.Entities:
Year: 2018 PMID： 29456792 PMCID： PMC5807874 DOI： 10.1021/acsmedchemlett.7b00374
Source DB: PubMed Journal: ACS Med Chem Lett ISSN： 1948-5875 Impact factor: 4.345